Atrial Flutter
... specifically amiodarone, can be used. Ischemic heart disease, sotalol or amiodarone can be used. (Avoid class IC agents) Significant systolic dysfunction, amiodarone and dofetilide can be used. (Avoid class IC agents) ...
... specifically amiodarone, can be used. Ischemic heart disease, sotalol or amiodarone can be used. (Avoid class IC agents) Significant systolic dysfunction, amiodarone and dofetilide can be used. (Avoid class IC agents) ...
Deadly Arrhythmia and ECGs
... • Ventricular Fibrillation/ Pulseless Ventricular Tachycardia • AVR – the forgotten lead in ECGs • All that ‘QT interval stuff’ • “Electrical alternans” ...
... • Ventricular Fibrillation/ Pulseless Ventricular Tachycardia • AVR – the forgotten lead in ECGs • All that ‘QT interval stuff’ • “Electrical alternans” ...
What is the cause of the regular wide QRS
... (1) Answers will be published in the SMJ August 2011 issue. (2) The MCR numbers of successful candidates will be posted online at www.sma.org.sg/cme/ smj by 04 August 2011. (3) All online submissions will receive an automatic email acknowledgment. (4) Passing mark is 60%. No mark will be deducted fo ...
... (1) Answers will be published in the SMJ August 2011 issue. (2) The MCR numbers of successful candidates will be posted online at www.sma.org.sg/cme/ smj by 04 August 2011. (3) All online submissions will receive an automatic email acknowledgment. (4) Passing mark is 60%. No mark will be deducted fo ...
Arrythmias and EKGs
... not be appropriate in the setting of severe cardiovascular decompensation ...
... not be appropriate in the setting of severe cardiovascular decompensation ...
Noncardiac surgery: Postoperative arrhythmias
... of three or more different P wave morphologies and an irregularly irregular rhythm. The most useful therapy for multifocal atrial tachycardia therapy is to treat the underlying causes, including hypoxemia and hypercapnia, myocardial ischemia, congestive heart failure, or electrolyte disturbances.  ...
... of three or more different P wave morphologies and an irregularly irregular rhythm. The most useful therapy for multifocal atrial tachycardia therapy is to treat the underlying causes, including hypoxemia and hypercapnia, myocardial ischemia, congestive heart failure, or electrolyte disturbances.  ...
Idiopathic ventricular tachycardia arising from the right ventricular apex
... to this case. They both have a predominant R-wave in augmented lead in contrast with the right outflow ventricular tachycardias because their axis is directed superiorly and leftwards. Although, this one is unique in that there is a later transition zone (V5–V6), probably due to a more sequential act ...
... to this case. They both have a predominant R-wave in augmented lead in contrast with the right outflow ventricular tachycardias because their axis is directed superiorly and leftwards. Although, this one is unique in that there is a later transition zone (V5–V6), probably due to a more sequential act ...
Peri-operative Cardiac Arrhythmias
... Adenosine 6mg IV bolus, given as a fast push and followed with a 20ml 0.9% saline flush. This rapidly blocks AV node conduction therefore slows the ventricular rate, cardioverting a junctional rhythm to sinus or terminating a re-entry SVT. If a second and third dose is needed, 12mg should be used wi ...
... Adenosine 6mg IV bolus, given as a fast push and followed with a 20ml 0.9% saline flush. This rapidly blocks AV node conduction therefore slows the ventricular rate, cardioverting a junctional rhythm to sinus or terminating a re-entry SVT. If a second and third dose is needed, 12mg should be used wi ...
Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation
... Patients qualifying for enrollment were of either sex and at least 21 years of age, had had at least one episode of atrial fibrillation (as seen on electrocardiography) in the preceding 3 months, and were in sinus rhythm for at least 1 hour before randomization. Excluded from the study were patients ...
... Patients qualifying for enrollment were of either sex and at least 21 years of age, had had at least one episode of atrial fibrillation (as seen on electrocardiography) in the preceding 3 months, and were in sinus rhythm for at least 1 hour before randomization. Excluded from the study were patients ...
Ibutilide Pretreatment to Facilitate Cardioversion of Refractory Atrial
... patients with body weight of 60 kg or more and 0.01 mg/kg for those with body weight less than 60 kg.22 A second dose of the same strength can be given to patients in whom cardioversion is not achieved after the first dose. There are no specific dosing recommendations for patients who are obese. Fur ...
... patients with body weight of 60 kg or more and 0.01 mg/kg for those with body weight less than 60 kg.22 A second dose of the same strength can be given to patients in whom cardioversion is not achieved after the first dose. There are no specific dosing recommendations for patients who are obese. Fur ...
Proceedings of the 33rd World Small Animal Veterinary
... • 2nd degree: In second degree AV block, some of the atrial depolarisation (P wave) does not result in a QRS complex - i.e. the P:QRS ratio is >1:1. The P - R interval may be variable, usually tending to increase prior to the block (Mobitz type I; the Wenckebach phenomenon) - this is another mani ...
... • 2nd degree: In second degree AV block, some of the atrial depolarisation (P wave) does not result in a QRS complex - i.e. the P:QRS ratio is >1:1. The P - R interval may be variable, usually tending to increase prior to the block (Mobitz type I; the Wenckebach phenomenon) - this is another mani ...
Paroxysmal supraventricular tachycardia: physiopathology and
... years, oral sotalol, a class III drug with beta-blocking properties, has been used increasingly often in the long-term treatment of paediatric supraventricular arrhythmias. Amiodarone is another class III antiarrhythmic drug. The main electrophysiological effect of amiodarone is to increase duration ...
... years, oral sotalol, a class III drug with beta-blocking properties, has been used increasingly often in the long-term treatment of paediatric supraventricular arrhythmias. Amiodarone is another class III antiarrhythmic drug. The main electrophysiological effect of amiodarone is to increase duration ...
digoxin - Cardiology
... Underlying rhythm can be sinus, atrial fibrillation, atrial flutter, atrial ...
... Underlying rhythm can be sinus, atrial fibrillation, atrial flutter, atrial ...
ANZCOR Guideline 11.5 – Medications in Adult Cardiac Arrest
... external cardiac compression. If a central line is present it should be used. Central access provides more rapid drug delivery but insertion of a new line may be difficult, takes time to establish and has major risks [Class A; Expert consensus opinion]. ...
... external cardiac compression. If a central line is present it should be used. Central access provides more rapid drug delivery but insertion of a new line may be difficult, takes time to establish and has major risks [Class A; Expert consensus opinion]. ...
ACLS Rhythms for the ACLS Algorithms
... ■ Accessory conduction pathway in many PSVT patients ■ For such otherwise healthy people many factors can provoke the paroxysm, such as ...
... ■ Accessory conduction pathway in many PSVT patients ■ For such otherwise healthy people many factors can provoke the paroxysm, such as ...
The EP Show
... Patients who have had a cardiac arrest, regardless of reason, need an ICD Amiodarone can be used as additional therapy or for those who may have recurring sustained ventricular tachycardia to limit ventricular intervention Klein ...
... Patients who have had a cardiac arrest, regardless of reason, need an ICD Amiodarone can be used as additional therapy or for those who may have recurring sustained ventricular tachycardia to limit ventricular intervention Klein ...
BS arrhythmias
... Blocks abnormal pacemakers in cells receiving excess catecholamines (e.g. pheochromocytoma) or up-regulated beta-receptors (ie. Hyperthyroidism) b. Blocks A-V nodal reentrant tachycardias; inhibits ectopic foci c. Propranolol used to treat supraventricular tachydysrhythmias d. Contraindicated in ven ...
... Blocks abnormal pacemakers in cells receiving excess catecholamines (e.g. pheochromocytoma) or up-regulated beta-receptors (ie. Hyperthyroidism) b. Blocks A-V nodal reentrant tachycardias; inhibits ectopic foci c. Propranolol used to treat supraventricular tachydysrhythmias d. Contraindicated in ven ...
Antiarrhythmic therapy in patients with atrial fibrillation
... Initiation of treatment aimed at maintaining sinus rhythm should be justified by the presence of persistent symptoms associated with atrial fibrillation episodes in patient. The updated guidelines on atrial fibrillation, taking into account the results of meta-analyzes and review papers confirming t ...
... Initiation of treatment aimed at maintaining sinus rhythm should be justified by the presence of persistent symptoms associated with atrial fibrillation episodes in patient. The updated guidelines on atrial fibrillation, taking into account the results of meta-analyzes and review papers confirming t ...
Quinidine for Pharmacological Cardioversion of Long-lasting
... for decades for maintenance of sinus rhythm after cardioversion with an efficacy comparable to flecainide, but it has been progressively abandoned after the discovering of its proarrhythmic effect causing torsade de pointes and ventricular fibrillation, even if evidence is controversia.l9 In 1990s s ...
... for decades for maintenance of sinus rhythm after cardioversion with an efficacy comparable to flecainide, but it has been progressively abandoned after the discovering of its proarrhythmic effect causing torsade de pointes and ventricular fibrillation, even if evidence is controversia.l9 In 1990s s ...
Arrhythmia in Pediatric
... Is regular or (regular) irregular tachycardia due to atrial activity at arate of 250-400/min, Because the atrioventricular node cannot transmit such rapid impulses, there is virtually always some degree of A-V block and the ventride respond to every 2nd – 4th atrial beat. In older children atrial fl ...
... Is regular or (regular) irregular tachycardia due to atrial activity at arate of 250-400/min, Because the atrioventricular node cannot transmit such rapid impulses, there is virtually always some degree of A-V block and the ventride respond to every 2nd – 4th atrial beat. In older children atrial fl ...
Cardiac Arrythmias
... • Is caracterized by rapid coarse “sawtooth” appearing atrial activity, at rate of 250 to 350 x min. ...
... • Is caracterized by rapid coarse “sawtooth” appearing atrial activity, at rate of 250 to 350 x min. ...
Management of Common Arrhythmias: Part II. Ventricular
... treatment.3 It is important to review medications, determine if stimulants are being used, and correct electrolyte abnormalities. If no underlying cause is found, the optimal approach is patient reassurance. Patients should be made aware of the potential dangers of antiarrhythmic drug therapy as det ...
... treatment.3 It is important to review medications, determine if stimulants are being used, and correct electrolyte abnormalities. If no underlying cause is found, the optimal approach is patient reassurance. Patients should be made aware of the potential dangers of antiarrhythmic drug therapy as det ...
Supraventricular tachycardia
... Of all the supraventricular tachycardias, atrial fibrillation is by far the most common and the most important. It may affect up to 4% of individuals aged 70 years or more. The risk of AF is measured by the presence of underlying cardiovascular disease including myocardial infarction and hypertensio ...
... Of all the supraventricular tachycardias, atrial fibrillation is by far the most common and the most important. It may affect up to 4% of individuals aged 70 years or more. The risk of AF is measured by the presence of underlying cardiovascular disease including myocardial infarction and hypertensio ...
Cryoablation Lesion with Atrial Arrhythmia after Fontan Operation
... (mainly K ion) responsible for repolarization. • Medications including amiodarone, bretylium, sotalol prolong the QT interval, useful in treating almost all types of supraventricular & ventricular arrhythmias, but bretylium generally limited to use in ischemic ventricular arrhythmia. • Side effects ...
... (mainly K ion) responsible for repolarization. • Medications including amiodarone, bretylium, sotalol prolong the QT interval, useful in treating almost all types of supraventricular & ventricular arrhythmias, but bretylium generally limited to use in ischemic ventricular arrhythmia. • Side effects ...
Amiodarone
Amiodarone is a class III antiarrhythmic agent used for various types of cardiac dysrhythmias, both ventricular and atrial. It was discovered in 1961. Despite relatively common side-effects, it is used in arrhythmias that are otherwise difficult to treat with medication.